Upstream Bio, Inc.
UPB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $1 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -27.1% | 65.5% | -7.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 95.5% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4,936.6% | -4,728.4% | -5,648.4% | -4,285.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4,941.1% | -4,265.3% | -4,818% | -3,465.3% |
| EPS Diluted | -0.63 | -0.74 | -0.51 | -0.41 |
| % Growth | 14.9% | -45.1% | -24.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |